Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder: A Randomized Controlled Trial

NCT06957210 is registered in ClinicalTrials.gov with Asad Ullah Jan as lead sponsor.

NCT NCT06957210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06957210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder: A Randomized Controlled Trial
Lead sponsor
Asad Ullah Jan
Phase
Not applicable
Overall status
Completed
Start date
May 6, 2025
Completion date
December 31, 2025
Enrollment
130 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd - post traumatic stress disorder